Dr Reddy's Q4 Profit Falls 86% YoY; Board Proposes Rs 8 Dividend Per Share
5 minutes agoBusiness
28LENS
4 SourcesNew Delhi, India
TBNthebalanced.news

Dr Reddy's Q4 Profit Falls 86% YoY; Board Proposes Rs 8 Dividend Per Share

Dr Reddy's Laboratories reported a significant 86% year-on-year decline in consolidated net profit to around Rs 220 crore for Q4FY26, with revenue falling approximately 12% to Rs 7,516 crore. The sequential quarter also saw declines in profit and revenue. The board recommended a final dividend of Rs 8 per share for FY26, subject to shareholder approval. Despite the quarterly drop, full-year revenue grew 3%, supported by favorable foreign exchange and broad-based market growth except in North America.

Political Bias
0%100%0%
Sentiment
46%
AI analysis of 4 sources · Published under editorial oversight by The Balanced News
Analysed 12 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 4 sources
● Left 0%● Center 100%● Right 0%

The articles present a primarily business-focused perspective without political framing. Coverage centers on financial performance, shareholder returns, and market factors, reflecting corporate and investor viewpoints. There is no evident political bias, as the sources report factual financial data and company announcements without partisan interpretation or political commentary.

Sentiment — Neutral (46/100)

The overall tone is neutral to slightly negative due to the sharp quarterly profit and revenue declines reported. However, the inclusion of full-year revenue growth and dividend proposals provides a balanced view, mitigating purely negative sentiment. The third article’s focus on stock performance and market analysis adds a neutral, informational dimension to the coverage.

How 4 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
news18Dr Reddy's Q4 PAT down 86 pc at Rs 221.3 crCenterNeutral
economictimesDr Reddy's Laboratories Q4 Results: Cons PAT falls 86 YoY to Rs 221 crore, revenue dips 12 ; Rs 8 per share dividend announcedCenterNeutral
mintDr Reddy's Q4 results 2026: Profit plunges 86 YoY to 220 crore; board recommends a final dividend of 8 Stock Market NewsCenterNegative
economictimesDr Reddys Share Price Live Updates: Dr. Reddy's Laboratories demonstrates consistent performance.CenterPositive

Coverage timeline

economictimes broke this story on 12 May, 03:32 am. Other outlets followed.

  1. 1
    economictimes12 May, 03:32 am
    Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories demonstrates consistent performance.
  2. 2
    mint12 May, 11:26 am
    Dr Reddy's Q4 results 2026: Profit plunges 86 YoY to 220 crore; board recommends a final dividend of 8 Stock Market News
  3. 3
    economictimes12 May, 11:53 am
    Dr Reddy's Laboratories Q4 Results: Cons PAT falls 86 YoY to Rs 221 crore, revenue dips 12 ; Rs 8 per share dividend announced
  4. 4
    news1812 May, 12:38 pm
    Dr Reddy's Q4 PAT down 86 pc at Rs 221.3 cr

Lens Score breakdown

28/100
Public interest0/100
Coverage gap90%

Well-covered story — coverage matches public importance.

Who's involved

Institutions and figures named across source coverage.

Corporate
Dr Reddy's LaboratoriesDr. Reddy's Laboratories

Story context

Category
Business
Location
New Delhi, India
Sources analysed
4
Last analysed
12 May 2026
Key entities
CroreIndian rupeeNet incomeDividendFiscal yearShareholderDr. Reddy's LaboratoriesEquity (finance)LenalidomideNorth AmericaEuropeFace value